Interleukin-11 expressed in the polyp-enriched fibroblast subset is a potential therapeutic target in Peutz-Jeghers syndrome.
Saved in:
| Title: | Interleukin-11 expressed in the polyp-enriched fibroblast subset is a potential therapeutic target in Peutz-Jeghers syndrome. |
|---|---|
| Authors: | Domènech-Moreno E; HiLIFE-Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland., Lim WW; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore, Singapore.; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore., Montrose MG; HiLIFE-Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland., Sévigny M; Translational Cancer Medicine Program, University of Helsinki, Helsinki, Finland.; Faculty of Biological and Environmental Sciences, Molecular and Integrative Biosciences Research Program, University of Helsinki, Helsinki, Finland., Brandt A; HiLIFE-Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland., Lemmetyinen TT; Translational Cancer Medicine Program, University of Helsinki, Helsinki, Finland.; Faculty of Biological and Environmental Sciences, Molecular and Integrative Biosciences Research Program, University of Helsinki, Helsinki, Finland., Viitala EW; Translational Cancer Medicine Program, University of Helsinki, Helsinki, Finland.; Faculty of Biological and Environmental Sciences, Molecular and Integrative Biosciences Research Program, University of Helsinki, Helsinki, Finland., Mäkelä TP; HiLIFE-Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland., Cook SA; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore, Singapore.; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore.; MRC-London Institute of Medical Sciences, Hammersmith Hospital Campus, London, UK., Ollila S; Translational Cancer Medicine Program, University of Helsinki, Helsinki, Finland.; Faculty of Biological and Environmental Sciences, Molecular and Integrative Biosciences Research Program, University of Helsinki, Helsinki, Finland. |
| Source: | The Journal of pathology [J Pathol] 2025 May; Vol. 266 (1), pp. 66-80. Date of Electronic Publication: 2025 Mar 11. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: John Wiley And Sons Country of Publication: England NLM ID: 0204634 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9896 (Electronic) Linking ISSN: 00223417 NLM ISO Abbreviation: J Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1096-9896 |
|---|---|
| DOI: | 10.1002/path.6408 |
